Rocket Pharmaceuticals Q3 EPS USD -0.43
RCKT•Rocket Pharmaceuticals reported Q3 net income of USD -49.2 million and EPS of USD -0.43.
1. Q3 results
Rocket Pharmaceuticals reported Q3 net income of USD -49.2 million and EPS of USD -0.43.
RCKT•RCKT•RCKT•Rocket Pharmaceuticals reported Q3 net income of USD -49.2 million and EPS of USD -0.43.
Rocket Pharmaceuticals reported Q3 net income of USD -49.2 million and EPS of USD -0.43.
